The pharmaceutical industry is undergoing a structural shift where ESG considerations are no longer peripheral but central to growth strategies. Increasing regulatory pressure, investor scrutiny, and stakeholder expectations are compelling companies to embed sustainability into core operations. In 2025, over 70% of global pharmaceutical firms reported enhanced ESG disclosures, reflecting a broader move toward transparency and accountability. Environmental concerns such as car

Sustainable investing (often grouped under ESG: Environmental, Social, and Governance ) is an approach to investing that aims to earn competitive financial returns while also considering a company’s long-run effects on society and the environment . Instead of looking only at revenue, profit, and growth, sustainable investors also evaluate factors like carbon emissions, worker safety, supply-chain labor practices, board oversight, and business ethics. sustainable investing! W

What is ESG Alpha? Alpha should sound familiar to all the finance professionals, especially in investment and portfolio management field. Then how about "ESG Alpha"?? ESG Alpha is a financial concept that refers to the excess returns (or "alpha") generated by an investment strategy that specifically integrates Environmental, Social, and Governance (ESG) factors. In traditional finance, "Alpha" measures an investment's performance relative to a benchmark index (like the S&P

https://www.bloomberg.com/professional/insights/sustainable-finance/record-sales-of-green-bonds-in-the-first-half-of-2024/ A sharp rebound in green bond issuance and investor demand during Jan–Jun 2024, with several markets seeing very large deal sizes, strong order books (often oversubscribed), and tighter pricing versus prior years. Relevant background (what drove the surge of green bonds) More stable rate expectations than 2022–2023 reopened primary bond markets, bringin